» Articles » PMID: 28625507

Contemporary Patterns of Care and Outcomes of Men Found to Have Lymph Node Metastases at the Time of Radical Prostatectomy

Overview
Journal J Urol
Publisher Wolters Kluwer
Specialty Urology
Date 2017 Jun 20
PMID 28625507
Citations 7
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose: A thorough understanding of the natural history and consensus regarding the optimal management of pathological lymph node positive (pN1) prostate cancer are lacking. Our objective was to describe patterns of care and outcomes of a contemporary cohort of men with pN1 prostate cancer.

Materials And Methods: We used the National Cancer Database to identify 7,791 men who were found to have lymph node metastases at radical prostatectomy. Multinomial logistic regression and Cox proportional hazards regression were used to identify patient, tumor and facility characteristics associated with the choice of management strategy after radical prostatectomy and overall survival, respectively.

Results: Initial post-prostatectomy management was observation in 63% of the men, androgen deprivation therapy alone in 20%, radiation therapy alone in 5%, and androgen deprivation therapy and radiation therapy in 13%. Younger age, lower comorbidity burden, higher grade and stage, and positive surgical margins were associated with a higher likelihood of receiving combination therapy. Grade group 4-5 disease, pT3b-T4 disease, positive surgical margins and a higher number of positive lymph nodes were independent predictors of worse overall survival. The adjusted 10-year overall survival probability decreased from 84% to 32% with the presence of an increasing number of adverse prognostic factors. Treatment with combined androgen deprivation therapy and radiation therapy was associated with better overall survival (multivariable HR 0.69, 95% CI 0.52-0.92, p = 0.010 for combination therapy vs observation).

Conclusions: Patient and tumor characteristics are associated with the choice of management strategy after radical prostatectomy and survival in men with pN1 prostate cancer. Multimodal therapy may be of benefit in this patient population.

Citing Articles

Development of machine learning prognostic models for overall survival of prostate cancer patients with lymph node-positive.

Peng Z, Tian J, Chen B, Zhou H, Bi H, He M Sci Rep. 2023; 13(1):18424.

PMID: 37891423 PMC: 10611782. DOI: 10.1038/s41598-023-45804-x.


Oncologic outcomes of patients with lymph node invasion at prostatectomy and post-prostatectomy biochemical persistence.

Perera M, Lebdai S, Tin A, Sjoberg D, Benfante N, Beech B Urol Oncol. 2022; 41(2):105.e19-105.e23.

PMID: 36435708 PMC: 10391319. DOI: 10.1016/j.urolonc.2022.10.021.


Current Status and Future Perspective on the Management of Lymph Node-Positive Prostate Cancer after Radical Prostatectomy.

Shiota M, Blas L, Eto M Cancers (Basel). 2022; 14(11).

PMID: 35681676 PMC: 9179902. DOI: 10.3390/cancers14112696.


Patients with Positive Lymph Nodes after Radical Prostatectomy and Pelvic Lymphadenectomy-Do We Know the Proper Way of Management?.

Malkiewicz B, Knura M, Latkowska M, Kobylanski M, Nagi K, Janczak D Cancers (Basel). 2022; 14(9).

PMID: 35565455 PMC: 9104304. DOI: 10.3390/cancers14092326.


Radiotherapy plus androgen deprivation therapy for prostate-specific antigen persistence in lymph node-positive prostate cancer.

Shiota M, Takamatsu D, Kimura T, Tashiro K, Matsui Y, Tomida R Cancer Sci. 2022; 113(7):2386-2396.

PMID: 35485635 PMC: 9277249. DOI: 10.1111/cas.15383.


References
1.
Kaplan J, Kowalczyk K, Borza T, Gu X, Lipsitz S, Nguyen P . Patterns of care and outcomes of radiotherapy for lymph node positivity after radical prostatectomy. BJU Int. 2013; 111(8):1208-14. DOI: 10.1111/bju.12079. View

2.
Wiegel T, Bottke D, Steiner U, Siegmann A, Golz R, Storkel S . Phase III postoperative adjuvant radiotherapy after radical prostatectomy compared with radical prostatectomy alone in pT3 prostate cancer with postoperative undetectable prostate-specific antigen: ARO 96-02/AUO AP 09/95. J Clin Oncol. 2009; 27(18):2924-30. DOI: 10.1200/JCO.2008.18.9563. View

3.
Bianchi L, Nini A, Bianchi M, Gandaglia G, Fossati N, Suardi N . The Role of Prostate-specific Antigen Persistence After Radical Prostatectomy for the Prediction of Clinical Progression and Cancer-specific Mortality in Node-positive Prostate Cancer Patients. Eur Urol. 2016; 69(6):1142-8. DOI: 10.1016/j.eururo.2015.12.010. View

4.
Abdollah F, Sun M, Thuret R, Budaus L, Jeldres C, Graefen M . Decreasing rate and extent of lymph node staging in patients undergoing radical prostatectomy may undermine the rate of diagnosis of lymph node metastases in prostate cancer. Eur Urol. 2010; 58(6):882-92. DOI: 10.1016/j.eururo.2010.09.029. View

5.
Abdollah F, Suardi N, Gallina A, Bianchi M, Tutolo M, Passoni N . Extended pelvic lymph node dissection in prostate cancer: a 20-year audit in a single center. Ann Oncol. 2013; 24(6):1459-66. DOI: 10.1093/annonc/mdt120. View